Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
My laboratory is interested in understanding the chemical modifications of our genome, transcriptome, and proteome in human health and disease – cancer in particular – and translating this information into diagnostic and therapeutic opportunities that ultimately benefit patients. To do so, we use our unique expertise in chemical biology to develop cutting-edge technologies to decode the wealth of epigenetic information. Most notably, we developed TAPS, a revolutionary bisulfite-free and base-resolution direct sequencing method for DNA epigenetic modifications. We have further demonstrated the application of TAPS in cell-free DNA for accurate identification of early liver cancer and pancreatic cancer. Our ongoing efforts aim to establish a comprehensive human epigenetic tissue atlas, as well as develop single-cell epigenetic sequencing to study tumour heterogeneity. We are also developing novel RNA modification sequencing methods to decipher the epitranscriptome in cancer.
